Omeros Corp (OMER) stock
OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.92−2.76 (-16.55%)
Close on Nov 17, 2026Market cap $1.01BP/E –Yield –
Omeros operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Omeros's operating cash flow for the twelve months ending Jun 30, 2026 was -$68.67M. For fiscal 2025 it was -$116.09M. The highest annual figure on record is $74.73M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$116.09M | – |
| FY2024 | Dec 31, 2024 | -$148.80M | -299.1% |
| FY2023 | Dec 31, 2023 | $74.73M | – |
| FY2022 | Dec 31, 2022 | -$86.48M | – |
| FY2021 | Dec 31, 2021 | -$109.72M | – |
| FY2020 | Dec 31, 2020 | -$100.09M | – |
| FY2019 | Dec 31, 2019 | -$60.07M | – |
| FY2018 | Dec 31, 2018 | -$103.74M | – |
| FY2017 | Dec 31, 2017 | -$36.23M | – |
| FY2016 | Dec 31, 2016 | -$51.50M | – |
| FY2015 | Dec 31, 2015 | -$65.21M | – |
| FY2014 | Dec 31, 2014 | -$58.04M | – |
| FY2013 | Dec 31, 2013 | -$29.70M | – |
| FY2012 | Dec 31, 2012 | -$34.55M | – |
| FY2011 | Dec 31, 2011 | -$25.67M | – |
| FY2010 | Dec 31, 2010 | -$14.50M | – |
| FY2009 | Dec 31, 2009 | -$19.03M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.15M | – |
| Q1 FY2026 | Mar 31, 2026 | -$14.51M | – |
| Q4 FY2025 | Dec 31, 2025 | -$39.84M | – |
| Q3 FY2025 | Sep 30, 2025 | -$18.47M | – |
| Q2 FY2025 | Jun 30, 2025 | -$21.94M | – |
| Q1 FY2025 | Mar 31, 2025 | -$35.84M | – |
| Q4 FY2024 | Dec 31, 2024 | -$28.98M | – |
| Q3 FY2024 | Sep 30, 2024 | -$32.06M | – |
| Q2 FY2024 | Jun 30, 2024 | -$45.99M | – |
| Q1 FY2024 | Mar 31, 2024 | -$41.78M | -123.9% |
| Q4 FY2023 | Dec 31, 2023 | -$34.83M | – |
| Q3 FY2023 | Sep 30, 2023 | -$32.65M | – |
| Q2 FY2023 | Jun 30, 2023 | -$32.34M | – |
| Q1 FY2023 | Mar 31, 2023 | $174.54M | – |
| Q4 FY2022 | Dec 31, 2022 | -$25.38M | – |
| Q3 FY2022 | Sep 30, 2022 | -$26.44M | – |
| Q2 FY2022 | Jun 30, 2022 | -$19.47M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.19M | – |
| Q4 FY2021 | Dec 31, 2021 | -$18.22M | – |
| Q1 FY2021 | Mar 31, 2021 | -$40.25M | – |
| Q4 FY2020 | Dec 31, 2020 | -$18.41M | – |
| Q3 FY2020 | Sep 30, 2020 | -$34.94M | – |
| Q2 FY2020 | Jun 30, 2020 | -$37.60M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.14M | – |
| Q4 FY2019 | Dec 31, 2019 | -$23.01M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.52M | – |
| Q2 FY2019 | Jun 30, 2019 | -$16.59M | – |
| Q1 FY2019 | Mar 31, 2019 | -$12.95M | – |
| Q4 FY2018 | Dec 31, 2018 | -$24.66M | – |
| Q3 FY2018 | Sep 30, 2018 | -$36.87M | – |
| Q2 FY2018 | Jun 30, 2018 | -$30.91M | – |
| Q1 FY2018 | Mar 31, 2018 | -$11.30M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.17M | – |
| Q3 FY2017 | Sep 30, 2017 | -$11.19M | – |
| Q2 FY2017 | Jun 30, 2017 | -$8.16M | – |
| Q1 FY2017 | Mar 31, 2017 | -$12.70M | – |
| Q4 FY2016 | Dec 31, 2016 | -$10.86M | – |
| Q3 FY2016 | Sep 30, 2016 | -$11.22M | – |
| Q2 FY2016 | Jun 30, 2016 | -$12.80M | – |
See a number that looks wrong?